To further validate the therapeutic potential of MDM4, we conducted study on the small molecule MDM4 inhibitor, NSC146109, in different tumor cell lines (kidney cancer: 786-O; breast cancer: MCF-7; lung cancer: A549; colon cancer: HCT116). This evidence concerns the gene MDM4 and colonic neoplasm.